Nippon Chemi-Con Corporation (FRA:NCZ)
Germany · Delayed Price · Currency is EUR 7.90
-0.10 (-1.25%)
At close: Jan 27, 2026
Nippon Chemi-Con Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 127,016 | 122,684 | 150,740 | 161,881 | 140,316 | 110,788 | |
Revenue Growth (YoY) | -2.53% | -18.61% | -6.88% | 15.37% | 26.65% | -3.33% |
Cost of Revenue | 104,176 | 98,955 | 118,875 | 124,954 | 109,063 | 89,641 |
Gross Profit | 22,840 | 23,729 | 31,865 | 36,927 | 31,253 | 21,147 |
Selling, General & Admin | 14,493 | 14,489 | 16,680 | 18,468 | 17,203 | 13,454 |
Research & Development | 4,228 | 4,228 | 4,489 | 4,383 | 4,156 | 3,710 |
Operating Expenses | 19,993 | 19,989 | 22,442 | 23,987 | 22,453 | 18,176 |
Operating Income | 2,847 | 3,740 | 9,423 | 12,940 | 8,800 | 2,971 |
Interest Expense | -1,480 | -1,526 | -1,472 | -1,001 | -795 | -727 |
Interest & Investment Income | 138 | 178 | 222 | 225 | 151 | 134 |
Earnings From Equity Investments | 846 | 833 | 508 | 619 | 545 | 345 |
Currency Exchange Gain (Loss) | 195 | -667 | 85 | -1,115 | -95 | -41 |
Other Non Operating Income (Expenses) | -499 | -991 | -853 | -676 | -567 | -592 |
EBT Excluding Unusual Items | 2,047 | 1,567 | 7,913 | 10,992 | 8,039 | 2,090 |
Gain (Loss) on Sale of Investments | - | - | 2,686 | - | - | 175 |
Gain (Loss) on Sale of Assets | -29 | -31 | -39 | -55 | -98 | -10 |
Other Unusual Items | -973 | -973 | -29,603 | -6,410 | -18,403 | - |
Pretax Income | 1,045 | 563 | -19,043 | 4,527 | -10,462 | 2,255 |
Income Tax Expense | 768 | 498 | 2,219 | 2,177 | 1,690 | 259 |
Earnings From Continuing Operations | 277 | 65 | -21,262 | 2,350 | -12,152 | 1,996 |
Minority Interest in Earnings | -49 | -28 | -29 | -77 | 28 | 42 |
Net Income | 228 | 37 | -21,291 | 2,273 | -12,124 | 2,038 |
Net Income to Common | 228 | 37 | -21,291 | 2,273 | -12,124 | 2,038 |
Shares Outstanding (Basic) | 21 | 21 | 21 | 20 | 20 | 18 |
Shares Outstanding (Diluted) | 42 | 40 | 21 | 20 | 20 | 18 |
Shares Change (YoY) | 56.42% | 91.40% | 2.02% | -0.01% | 14.02% | 9.23% |
EPS (Basic) | 10.68 | 1.73 | -1029.15 | 112.09 | -597.86 | 114.73 |
EPS (Diluted) | 5.41 | 0.95 | -1029.15 | 112.09 | -597.86 | 114.63 |
Free Cash Flow | -5,612 | -9,818 | -21,870 | -11,119 | 74 | -1,146 |
Free Cash Flow Per Share | -132.46 | -247.95 | -1057.13 | -548.33 | 3.65 | -64.44 |
Gross Margin | 17.98% | 19.34% | 21.14% | 22.81% | 22.27% | 19.09% |
Operating Margin | 2.24% | 3.05% | 6.25% | 7.99% | 6.27% | 2.68% |
Profit Margin | 0.18% | 0.03% | -14.12% | 1.40% | -8.64% | 1.84% |
Free Cash Flow Margin | -4.42% | -8.00% | -14.51% | -6.87% | 0.05% | -1.03% |
EBITDA | 9,951 | 10,829 | 16,185 | 19,272 | 15,053 | 9,020 |
EBITDA Margin | 7.83% | 8.83% | 10.74% | 11.91% | 10.73% | 8.14% |
D&A For EBITDA | 7,104 | 7,089 | 6,762 | 6,332 | 6,253 | 6,049 |
EBIT | 2,847 | 3,740 | 9,423 | 12,940 | 8,800 | 2,971 |
EBIT Margin | 2.24% | 3.05% | 6.25% | 7.99% | 6.27% | 2.68% |
Effective Tax Rate | 73.49% | 88.45% | - | 48.09% | - | 11.49% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.